Dudediligence.

uniQure N.V.

QURENASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.3MSep ’24$5.2MDec ’24$1.6MMar ’25$5.3MJun ’25$3.7MSep ’25$5.6MDec ’25$3.6MMar ’26$5.8MJun ’26
Net income, by quarter
−$44.4MSep ’24−$73.3MDec ’24−$43.6MMar ’25−$37.7MJun ’25−$80.5MSep ’25−$37.1MDec ’25−$53.5MMar ’26−$81.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$524.0M$106.5M$15.8M$27.1M$16.1M
Gross profit$499.0M$105.2M$15.8M$25.9M$14.4M
Operating income$310.6M−$143.2M−$282.9M−$184.3M−$185.3M
Net income$329.6M−$126.8M−$308.5M−$239.6M−$199.0M
Operating cash flow$288.0M−$145.1M−$145.9M−$182.7M−$178.0M
Free cash flow$270.5M−$162.7M−$153.1M−$186.1M−$178.4M
Cash$556.3M$228.0M$241.4M$158.9M$80.2M
Debt$101.0M$102.8M$101.7M$51.3M$49.7M
Shares outstanding46.3M47.0M47.8M49.0M62.3M